100 related articles for article (PubMed ID: 8193282)
1. Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients.
Roselli M; Guadagni F; Buonomo O; Lombardo A; Diodati A; Vittorini V; Belardi A; Cipriani C; Casciani CU
In Vivo; 1993; 7(6B):615-21. PubMed ID: 8193282
[TBL] [Abstract][Full Text] [Related]
2. Tumor markers as targets for selective diagnostic and therapeutic procedures.
Roselli M; Guadagni F; Buonomo O; Belardi A; Ferroni P; Diodati A; Anselmi D; Cipriani C; Casciani CU; Greiner J; Schlom J
Anticancer Res; 1996; 16(4B):2187-92. PubMed ID: 8694541
[TBL] [Abstract][Full Text] [Related]
3. From monoclonal antibodies to peptides and molecular recognition units: an overview.
Serafini AN
J Nucl Med; 1993 Mar; 34(3 Suppl):533-6. PubMed ID: 8441052
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and clinical evaluation of 125I-radiolabeled humanized CC49 monoclonal antibody (HuCC49deltaC(H)2) in recurrent and metastatic colorectal cancer patients.
Xiao J; Horst S; Hinkle G; Cao X; Kocak E; Fang J; Young D; Khazaeli M; Agnese D; Sun D; Martin E
Cancer Biother Radiopharm; 2005 Feb; 20(1):16-26. PubMed ID: 15778575
[TBL] [Abstract][Full Text] [Related]
5. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
6. Diagnostic use of radiolabeled antibodies for cancer.
Harrison KA; Tempero MA
Oncology (Williston Park); 1995 Jul; 9(7):625-31 DISC 634, 636, 641. PubMed ID: 8924373
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies in the diagnosis and therapy of lung cancer].
Campobasso N; Dammacco F
Recenti Prog Med; 1991 Dec; 82(12):642-51. PubMed ID: 1667710
[TBL] [Abstract][Full Text] [Related]
8. Improved tumor radioimmunodetection using a single-chain Fv and gamma-interferon: potential clinical applications for radioimmunoguided surgery and gamma scanning.
Nieroda CA; Milenic DE; Carrasquillo JA; Scholm J; Greiner JW
Cancer Res; 1995 Jul; 55(13):2858-65. PubMed ID: 7796413
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 region.
Rogers BE; Roberson PL; Shen S; Khazaeli MB; Carpenter M; Yokoyama S; Brechbiel MW; LoBuglio AF; Buchsbaum DJ
Cancer Biother Radiopharm; 2005 Oct; 20(5):502-13. PubMed ID: 16248766
[TBL] [Abstract][Full Text] [Related]
10. Tumour imaging with radiolabelled monoclonal antibodies.
Britton KE
Wien Klin Wochenschr; 1994; 106(2):35-6. PubMed ID: 8146993
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies and colorectal carcinoma: a clinical review of diagnostic applications.
Kuhn JA; Thomas G
Cancer Invest; 1994; 12(3):314-23. PubMed ID: 8187009
[No Abstract] [Full Text] [Related]
12. Improved tumor targeting by combined use of two antitenascin antibodies.
Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunoguided surgery for colorectal carcinoma.
Filez L; Penninckx F; Ectors N; Van Cutsem E; Geboes K; Aerts R; D'Hoore A; Kerremans R
Hepatogastroenterology; 1999; 46(26):691-700. PubMed ID: 10370597
[No Abstract] [Full Text] [Related]
14. Role of radioimmunolocalization in the staging of gastric carcinoma.
Mussa A; Sandrucci S; Mobiglia A; Baccega M; Mussa B; De Filippi PG
Semin Surg Oncol; 1998 Dec; 15(4):209-11. PubMed ID: 9829372
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer.
Stocchi L; Nelson H
Dis Colon Rectum; 1998 Feb; 41(2):232-50. PubMed ID: 9556250
[TBL] [Abstract][Full Text] [Related]
16. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.
Colcher D; Keenan AM; Larson SM; Schlom J
Cancer Res; 1984 Dec; 44(12 Pt 1):5744-51. PubMed ID: 6498836
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma detection with a combination of radiolabeled monoclonal antibodies. Promising results from immunohistochemistry studies.
Mangili F; Sassi I; Di Rocco M; Leone BE; Garancini P; Santambrogio G
Cancer; 1996 Dec; 78(11):2334-9. PubMed ID: 8941003
[TBL] [Abstract][Full Text] [Related]
18. Targeting of cancer with radiolabeled antibodies. Prospects for imaging and therapy.
Goldenberg DM
Arch Pathol Lab Med; 1988 Jun; 112(6):580-7. PubMed ID: 3288167
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
[TBL] [Abstract][Full Text] [Related]
20. Recent achievements in the development of radiolabeled monoclonal antibodies for diagnosis, therapy and biologic characterization of human tumors.
Larson SM; Macapinlac HA; Scott AM; Divgi CR
Acta Oncol; 1993; 32(7-8):709-15. PubMed ID: 8305216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
